• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆、脑脊液和尿液中内皮素-1免疫反应性的测定。

Determination of endothelin-1 immunoreactivity in plasma, cerebrospinal fluid and urine.

作者信息

Rolinski B, Sadri I, Bogner J, Goebel F D

机构信息

Medizinische Poliklinik, University of Munich, Germany.

出版信息

Res Exp Med (Berl). 1994;194(1):9-24. doi: 10.1007/BF02576362.

DOI:10.1007/BF02576362
PMID:8202641
Abstract

Endothelin-1 (ET-1) is a potent vasoconstrictor peptide apparently involved in a number of vascular diseases in man. Nonetheless, its determination in biological samples is difficult, and data on plasma or urine concentrations are controversial. We investigated different sample preparation procedures as well as different radioimmunoassays for their influence on ET-1 measurement. Recovery of ET-1 depended on the extraction procedure, the type and size of the extraction columns and on the biological matrix itself. Incomplete removal of matrix components by the extraction leads to the formation of particulate matter in the evaporated eluate. When dissolved in assay buffer, ET-1 was found to be absorbed to and only partly released from these particulates, so that it was not accessible for measurement in a radioimmunoassay. This was the case for all extraction procedures investigated except for that involving acetic acid. HPLC analysis of spiked samples revealed that ET-1 is in part degraded during extraction, most probably to Meth-sulphoxide ET-1. Dilution curves of synthetic pure ET-1 standards from different suppliers, prepared either in plasma with subsequent extraction or in assay buffer of the respective radioimmunoassay, resulted in considerable differences in the measured values for ET-1-immunoreactivity. Every radioimmunoassay tested had a specific pattern of recognizing different synthetic ET-1 standards. In conclusion, the measurement of ET-1-immunoreactivity is strongly influenced by the experimental conditions of sample preparation as well as by the radioimmunoassay employed.

摘要

内皮素 -1(ET -1)是一种强效血管收缩肽,显然与人类的多种血管疾病有关。尽管如此,在生物样品中测定它却很困难,而且关于血浆或尿液浓度的数据存在争议。我们研究了不同的样品制备程序以及不同的放射免疫测定法对ET -1测量的影响。ET -1的回收率取决于提取程序、提取柱的类型和大小以及生物基质本身。提取过程中基质成分去除不完全会导致蒸发洗脱液中形成颗粒物。当溶解在测定缓冲液中时,发现ET -1会吸附到这些颗粒物上且只有部分从颗粒物上释放出来,因此在放射免疫测定中无法进行测量。除了涉及乙酸的提取程序外,所有研究的提取程序都是这种情况。对加标样品的HPLC分析表明,ET -1在提取过程中部分降解,最有可能降解为甲硫氧化物ET -1。不同供应商的合成纯ET -1标准品的稀释曲线,无论是在血浆中制备随后提取,还是在各自放射免疫测定的测定缓冲液中制备,ET -1免疫反应性的测量值都存在相当大的差异。所测试的每种放射免疫测定都有识别不同合成ET -1标准品的特定模式。总之,ET -1免疫反应性的测量受到样品制备的实验条件以及所采用的放射免疫测定的强烈影响。

相似文献

1
Determination of endothelin-1 immunoreactivity in plasma, cerebrospinal fluid and urine.血浆、脑脊液和尿液中内皮素-1免疫反应性的测定。
Res Exp Med (Berl). 1994;194(1):9-24. doi: 10.1007/BF02576362.
2
Endothelin-1- and endothelin-3-like immunoreactivity in human cerebrospinal fluid.人脑脊液中内皮素-1和内皮素-3样免疫反应性
J Cardiovasc Pharmacol. 1991;17 Suppl 7:S434-6. doi: 10.1097/00005344-199100177-00124.
3
[Endothelin-1 and endothelin-3 in the plasma of dogs].
Tierarztl Prax. 1993 Feb;21(1):63-6.
4
Long term monitoring of immunoreactive endothelin-1 and endothelin-3 in ventricular cerebrospinal fluid, plasma, and 24-h urine of patients with subarachnoid hemorrhage.蛛网膜下腔出血患者脑室脑脊液、血浆及24小时尿液中免疫反应性内皮素-1和内皮素-3的长期监测。
Res Exp Med (Berl). 1992;192(4):257-68. doi: 10.1007/BF02576282.
5
Development and application of three radioimmunoassays of endothelin of varying specificities.三种不同特异性内皮素放射免疫测定法的开发与应用。
J Cardiovasc Pharmacol. 1991;17 Suppl 7:S425-6. doi: 10.1097/00005344-199100177-00121.
6
Radioimmunoassay of endothelin in human plasma.人血浆中内皮素的放射免疫测定
Blood Press. 1992 Oct;1(3):181-6. doi: 10.3109/08037059209077515.
7
[Validation of radioimmunoassay of tissue and plasma endothelin-1].[组织和血浆内皮素-1放射免疫分析的验证]
Arch Mal Coeur Vaiss. 1990 Jul;83(8):1263-5.
8
Critical factors in the radioimmunoassay of endothelin-1, endothelin-3, and big endothelin-1 in human plasma.人血浆中内皮素-1、内皮素-3和大内皮素-1放射免疫测定的关键因素
Anal Biochem. 2000 Feb 15;278(2):143-9. doi: 10.1006/abio.1999.4451.
9
Endothelin-1-like immunoreactivity in human urine.人尿中的内皮素-1样免疫反应性
Nephron. 1991;57(1):36-9. doi: 10.1159/000186212.
10
Endothelin immunoreactivity in cerebrospinal fluid of patients with subarachnoid haemorrhage.蛛网膜下腔出血患者脑脊液中的内皮素免疫反应性
Ann Med. 1990;22(4):233-6. doi: 10.3109/07853899009148932.

引用本文的文献

1
Plasma pro-endothelin-1 peptide concentrations rise in chronic kidney disease and following selective endothelin A receptor antagonism.慢性肾脏病患者以及选择性内皮素A受体拮抗治疗后,血浆前内皮素-1肽浓度升高。
J Am Heart Assoc. 2015 Mar 23;4(3):e001624. doi: 10.1161/JAHA.114.001624.
2
Endothelin-A receptor antagonism modifies cardiovascular risk factors in CKD.内皮素 A 受体拮抗作用可改变 CKD 患者的心血管危险因素。
J Am Soc Nephrol. 2013 Jan;24(1):31-6. doi: 10.1681/ASN.2012040355. Epub 2012 Dec 14.
3
Urinary endothelin-1 in chronic kidney disease and as a marker of disease activity in lupus nephritis.
慢性肾脏病中的尿内皮素-1以及作为狼疮性肾炎疾病活动的标志物
Am J Physiol Renal Physiol. 2009 Jun;296(6):F1477-83. doi: 10.1152/ajprenal.90713.2008. Epub 2009 Mar 11.
4
Endothelin-1 contributes to maintenance of systemic but not portal haemodynamics in patients with early cirrhosis: a randomised controlled trial.内皮素-1对早期肝硬化患者全身血流动力学而非门静脉血流动力学的维持有作用:一项随机对照试验。
Gut. 2006 Sep;55(9):1290-5. doi: 10.1136/gut.2005.077453. Epub 2006 Jan 24.
5
Enhanced vasodilatation to endothelin antagonism in patients with compensated cirrhosis and the role of nitric oxide.代偿期肝硬化患者对内皮素拮抗作用的血管舒张增强及一氧化氮的作用
Gut. 2003 Mar;52(3):410-5. doi: 10.1136/gut.52.3.410.
6
Regulation of peripheral vascular tone in patients with heart failure: contribution of angiotensin II.心力衰竭患者外周血管张力的调节:血管紧张素II的作用
Heart. 1998 Aug;80(2):134-40. doi: 10.1136/hrt.80.2.134.
7
Endothelin-1 immunoreactivity in plasma is elevated in HIV-1 infected patients with retinal microangiopathic syndrome.
Clin Investig. 1994 Mar;72(4):288-93. doi: 10.1007/BF00180042.